Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Prolymphocytic, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Myeloid, Acute 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Myeloid 1Leukemia, Large Granular Lymphocytic 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 24Cyclophosphamide 22Whole-Body Irradiation 18Mycophenolic Acid 16Cyclosporine 15Tacrolimus 12Busulfan 12Etoposide 11Antilymphocyte Serum 11Methotrexate 9Melphalan 9Bortezomib 9Rituximab 8Filgrastim 8Carboplatin 7Therapeutics 6Lenalidomide 6Everolimus 6Doxorubicin 6Vorinostat 5Radiotherapy 5Prednisone 5Flow Cytometry 5Alemtuzumab 5tanespimycin 4Vincristine 4Sirolimus 4Psychiatric Rehabilitation 4Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × Sensitivity and Specificity × Other hematologic neoplasm × Clear all
NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase 1/2 Unknown
10 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡